Education Library

Rick Clark, CPC, CPMA, discusses hospital reimbursement, provider reimbursement, and documentation best practices at an educational event for advanced practice providers (APPs).

Four physicians from the heart team at Tampa General Hospital discusses their approach to high-risk revascularization in patients with heart failure.

Fadi Al-Rashid, MD, discusses his publication on standard pre-procedural clinical workup for Protected PCI.

Seth Bilazarian, MD, and Chuck Simonton, MD, recap the kick-off Day of Innovation and highlights from Day 1 at TCT 2023 in San Francisco, CA.

Prof. Dr. Jan-Malte Sinning discusses optimal revascularization strategies during protected high-risk procedures with Impella® heart pumps.

William O’Neill, MD, and Alejandro Lemor, MD, compare insurance databases to the cVAD registry and discuss factors that characterize high-risk patients requiring MCS.

Alejandro F. Lemor, MD, disusses A-SMART-EF, a new risk score for predicting outcomes in patients supported with Impella® during PCI.

William O’Neill, MD, defines high-risk PCI and explains how to decide when to use mechanical circulatory support in this short interview.

Prof. Christophe Vandenbriele, MD, urges caution and the need for context when drawing conclusions from retrospective analyses in critically ill patients with cardiogenic shock.

Birgit Markus, MD, discusses data on the impact of Impella® heart pump support on hemodynamics and renal function in patients with cardiogenic shock.

Jürgen Leick, MD, discusses his paper on optimizing patient selection in high-risk protected percutaneous coronary intervention.

Prof. Dr. Christophe Vandenbriele discusses his recently published paper on anticoagulation in patients underoing Protected PCI procedures.

Prof. Karim Ibrahim discusses his article describing best practices for handling high-risk patients in the cardiac catheterization laboratory.

Vasileios Panoulas, MD, discusses a pooled analysis of factors predicting outcomes at 90 days in high-risk PCI patients.

Learn more about the data and differences between part I and part II from the York data analysis.